And if you've really fallen off the bandwagon, a 30-day reset might be what you need. "Sometimes we need to do a complete overhaul of something in order to change that habit," Daniella Cohn, RD, explains. "Following a temporary diet that eliminates all of the junk that we tend to eat daily can be a great way to remind ourselves to pay attention to what we are eating and make healthy and informed food choices."
And she has a point: Many of the foods on the "no" list have nutritional benefits and can be a smart addition to a healthy diet. "Whole grains, beans and yogurt are really important for our gut health, yet on this diet, they are not allowed," says Brooke Zigler, RD. "By eliminating these food groups, people could be missing out on key nutrients in their diet."
^ Ramsden, C.; Faurot, K.; Carrera-Bastos, P.; Cordain, L.; De Lorgeril, M.; Sperling, L. (2009). "Dietary Fat Quality and Coronary Heart Disease Prevention: A Unified Theory Based on Evolutionary, Historical, Global, and Modern Perspectives". Current Treatment Options in Cardiovascular Medicine. 11 (4): 289–301. doi:10.1007/s11936-009-0030-8. PMID 19627662.
This is Hartwig's No. 1 tip when it comes to success on the Whole30. No more grabbing a slice of pizza on the way home from work. "Before day one, you should have your first week of meals planned, grocery shopping done, pantry stocked, and you should have some Whole30-compliant emergency food stashed away," Hartwig says. Here's a Whole30-approved grocery list to get you started.
Go heavy on the veggies. For example, at lunch and dinner, make them three quarters of your plate, with one quarter occupied by meat—instead of the other way around. If you’re okay with just Paleo-ish, you could even replace a few meat dishes each week with a plant-based meal that incorporates legumes or Greek yogurt (cue the fainting of Paleo purists).
Dr. Uffe Ravnskov reviews the ongoing statins debate by comparing his recent publication, “LDL-C does not cause cardiovascular disease,” and the pro-statin claims of the editors of Circulation and the Cholesterol Treatment Trialists’ (CTT) Collaboration. He (along with Drs. Zoë Harcombe and Malcolm Kendrick) notes critical errors and obfuscation in the CTT’s recent Lancet meta-analysis and observes that the published data on coronary mortality, serious adverse events, and statin side effects is misrepresented, not statistically significant, or not provided for further analysis.